Country: Israel
Language: English
Source: Ministry of Health
IMATINIB AS MESYLATE
TEVA ISRAEL LTD
L01XE01
FILM COATED TABLETS
IMATINIB AS MESYLATE 100 MG
PER OS
Required
TEVA ISRAEL LTD, ISRAEL
IMATINIB
For the treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia(Ph+ -CML) in chronic phase accelerated phase or blast crisis.Imatinib Teva is also indicated for the treament of :Adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) integrated with chemotherapy.Adult patients with relapsed or refractory Ph + ALL as monotherapy.Adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.Adult patients with myelodyspiastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR ( platelet - derived growth factor receptor ) gene re- arrangements.Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) who have the FIP1L1- PDGFRalfa fusion kinase (mutational analysis or FISH demonstration fo CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFR alfa fusion kinase negative .Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation.Imatinib Teva is also indicated for the treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST)Imatinib Teva is also indicated for Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.
2020-06-30
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 THE MEDICINE IS DISPENSED WITH A DOCTOR’S PRESCRIPTION ONLY IMATINIB TEVA 100 MG FILM-COATED TABLETS COMPOSITION: Each film-coated tablet contains: Imatinib (as mesylate) 100 mg IMATINIB TEVA 400 MG FILM-COATED TABLETS COMPOSITION: Each film-coated tablet contains: Imatinib (as mesylate) 400 mg For information regarding inactive ingredients and allergens, see section 2 “Important information about some of the ingredients of the medicine” and section 6 “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. Keep this leaflet. You may have to read it again. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Imatinib Teva is a medicine that contains the active ingredient imatinib. The medicine works by inhibiting the production of abnormal cells in the diseases listed below, some of which are certain types of cancer. Imatinib Teva is intended for the treatment of adults and children aged 3 and above, with Philadelphia chromosome-positive chronic myeloid leukemia, in the chronic phase, accelerated phase or blast crisis phase. Imatinib Teva is intended for the treatment of adults with Kit (CD117)-positive malignant metastatic and/or unresectable gastrointestinal stromal tumors (GIST). Imatinib Teva is intended as an adjuvant treatment in adults after complete surgical resection of the Kit (CD117)-positive gastrointestinal stromal tumor (GIST). Imatinib Teva is intended for the treatment of adults with newly diagnosed Philadelphia chromosome- positive acute lymphoblastic leukemia (ALL), in combination with chemotherapy. Imatinib Teva is intended for the treatment of adults with relapsed or refractory Philade Read the complete document